These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17502675)

  • 1. Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.
    Shen S; Tan TH; Tan YJ
    Methods Mol Biol; 2007; 379():127-35. PubMed ID: 17502675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein.
    Song HC; Seo MY; Stadler K; Yoo BJ; Choo QL; Coates SR; Uematsu Y; Harada T; Greer CE; Polo JM; Pileri P; Eickmann M; Rappuoli R; Abrignani S; Houghton M; Han JH
    J Virol; 2004 Oct; 78(19):10328-35. PubMed ID: 15367599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein.
    Han DP; Kim HG; Kim YB; Poon LL; Cho MW
    Virology; 2004 Aug; 326(1):140-9. PubMed ID: 15262502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M.
    Oostra M; de Haan CA; de Groot RJ; Rottier PJ
    J Virol; 2006 Mar; 80(5):2326-36. PubMed ID: 16474139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion.
    Petit CM; Melancon JM; Chouljenko VN; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2005 Oct; 341(2):215-30. PubMed ID: 16099010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
    Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
    J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.
    Bisht H; Roberts A; Vogel L; Bukreyev A; Collins PL; Murphy BR; Subbarao K; Moss B
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6641-6. PubMed ID: 15096611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
    Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD
    J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of SARS spike gene in Shizomycete pombe].
    Wu ZX; Zheng WL; Zhang B; Shi YX; Wen-Li
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):638-41. PubMed ID: 16176106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization.
    Chen J; Miao L; Li JM; Li YY; Zhu QY; Zhou CL; Fang HQ; Chen HP
    World J Gastroenterol; 2005 Oct; 11(39):6159-64. PubMed ID: 16273643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.
    Zhou Y; Lu K; Pfefferle S; Bertram S; Glowacka I; Drosten C; Pöhlmann S; Simmons G
    J Virol; 2010 Sep; 84(17):8753-64. PubMed ID: 20573835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein.
    Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY
    Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prokaryotic expression of SARS coronavirus spike protein and construction of its DNA vaccine].
    Li JN; Xiang KJ; Zhou R; Huang CH; Ding YQ; Zeng QY; Zhong QP
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):33-6. PubMed ID: 15683993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus.
    Kitabatake M; Inoue S; Yasui F; Yokochi S; Arai M; Morita K; Shida H; Kidokoro M; Murai F; Le MQ; Mizuno K; Matsushima K; Kohara M
    Vaccine; 2007 Jan; 25(4):630-7. PubMed ID: 17011679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion.
    Petit CM; Chouljenko VN; Iyer A; Colgrove R; Farzan M; Knipe DM; Kousoulas KG
    Virology; 2007 Apr; 360(2):264-74. PubMed ID: 17134730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
    Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP; Chen CY; Liu SJ; Chen KH; Lee YM; Chao YC; Chen YM
    J Virol; 2006 Nov; 80(21):10315-24. PubMed ID: 17041212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells.
    Geyer H; Kempf R; Schott HH; Geyer R
    Eur J Biochem; 1990 Nov; 193(3):855-62. PubMed ID: 2174368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
    Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
    Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Receptor-binding ability of fragments 260-600 and 397-796 of SARS-associated coronavirus spike protein].
    Wei HY; Wang JW; Ou YJ; Wang YB; Qu JG; Zhao WM; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):353-7. PubMed ID: 16415994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.